ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas2026
The flavonoid isoliquiritigenin promotes lifespan extension of Caenorhabditis elegans through the transcription factor DAF-16 and aquaporin-2.
Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is associated with the accumulation of oxidative damage. Isoliquiritigenin (ISL), a natural flavonoid, exhibits antioxidant properties, but its effect on lifespan and the underlying mechanisms remains incompletely understood. This study aimed to investigate whether ISL extends lifespan in Caenorhabditis elegans through the transcription factor DAF-16 and the aquaporin AQP-2. We employed lifespan assays, stress resistance tests, intracellular ROS measurement, osmotic water permeability assays in Xenopus oocytes, genetic manipulation (using mutants and RNAi), quantitative real-time PCR, and fluorescence microscopy to assess DAF-16 localization and target gene expression. ISL extended the mean lifespan of wild-type C. elegans by 15.35% at 20 μM (P<0.01). It enhanced resistance to oxidative stress (36.54% higher survival under paraquat) and heat shock (20.56% higher survival at 37°C), and reduced intracellular ROS levels. Mechanistically, ISL increased DAF-16 nuclear translocation by 44.3% (P=0.003), and upregulated the expression of its target genes, including sod-3 (3.2-fold, P=0.008) and aqp-2 (2.9-fold, P=0.012). ISL also increased the osmotic water permeability of Xenopus oocytes by 1.7-fold (P=0.007), and the effect was abolished by the aquaporin inhibitor HgCl2. Genetic ablation of aqp-2 nullified ISL-induced lifespan extension (P=0.65 vs control) and ROS reduction. Crucially, aqp-2 RNAi suppressed ISL-driven DAF-16 nuclear accumulation and sod-3 expression, establishing a feedforward loop. ISL extended lifespan and enhanced stress resistance in C. elegans by activating a DAF-16/AQP-2 regulatory module, thereby linking water homeostasis to the transcriptional control of aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.